Treatment of Hodgkin Lymphoma: A 50-Year Perspective-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment of Hodgkin Lymphoma: A 50-Year Perspective

Published:2014-01-20 Issue:3 Volume:32 Page:163-168
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Canellos George P.¹,Rosenberg Saul A.²,Friedberg Jonathan W.³,Lister T. Andrew⁴,DeVita Vincent T.⁵

Affiliation:

1. Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

2. Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA

3. James P. Wilmont Cancer Center, University of Rochester, Rochester, NY

4. Barts Cancer Institute, University of London, London, United Kingdom

5. Yale Cancer Center, Yale University School of Medicine, New Haven, CT

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Reference61 articles.

1. Combination Chemotherapy in the Treatment of Advanced Hodgkin's Disease

2. The impact of breakthrough clinical trials on survival in population based tumor registries

3. H Jackson Jr, F Parker Jr: Hodgkin's Disease and Allied Disorders 41– 42,1947 New York, NY Oxford University Press

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hodgkin lymphoma and liquid biopsy: a story to be told;Journal of Experimental & Clinical Cancer Research;2024-07-02

2. Pathogenic Variants Associated with Epigenetic Control and the NOTCH Pathway Are Frequent in Classic Hodgkin Lymphoma;International Journal of Molecular Sciences;2024-02-20

3. Prognostic Impact of Serum β2-Microglobulin Levels in Hodgkin Lymphoma Treated with ABVD or Equivalent Regimens: A Comprehensive Analysis of 915 Patients;Cancers;2024-01-05

4. An International Survey Investigating the Incidence and Management of Brown Fat Uptake on¹⁸F-FDG PET/CT at Children’s Hospitals and Interventions for Mitigation;Journal of Nuclear Medicine Technology;2023-12-13

5. Starting and stopping cancer drugs: The need for randomized trials;Journal of Cancer Policy;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3